Cerus Corp. (CERS)

NASDAQ

$2.37

$+0.05

(+2.16%)

Regular Market

Cerus Corp. (CERS) Live Price Chart

Last updated: ⁦2026-10-21 16:15:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cerus Corp. (CERS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.37, with a market capitalization of $447.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.38 to $3.47. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$447.39M
Open	$2.31
Day's High	$14.76
Day's Low	$0.55
Previous Close	$2.31
Volume	905.65K
Average Volume	2.14M
P/E Ratio	--
52-Week High	$3.47
52-Week Low	$1.38
Dividend Yield	--
Earnings Date	--

Cerus Corp. (CERS) Stock Price Today

Cerus Corp. (CERS) is currently trading at $2.37 as of 2026-10-21 15:58:56, up 2.38% ($0.06) from the previous close of $2.31

During today's regular trading session, CERS has traded between $0.55 and $14.76, with a trading volume of 905.65K shares. The current price is near the lower end of today's range.

Cerus Corp. (CERS) 7-Day Stock Price Change

Over the past seven days, Cerus Corp. (CERS) moved from $2.26 to $2.37, representing a gain of 4.65% ($0.11).

The stock traded between $2.12 and $2.37 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.99 million shares, up versus the previous seven-day period, indicating higher trading activity.

CERS 52-Week Price Position

Position in Range: 47.1%

52W Low$1.38

52W High$3.47

CERS is currently trading at $2.37, placing it 47.1% of the way from its 52-week low of $1.38 to its 52-week high of $3.47. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cerus Corp. (CERS)?

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Cerus Corp. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	345
Exchange	NASDAQ
Company Website	https://www.cerus.com

How to Buy Cerus Corp. (CERS) Stock on MEXC

Eligible investors can buy real shares of Cerus Corp. (CERS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CERS and Place Your Order

Open the RealStocks trading page and search for CERS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cerus Corp. (CERS) stock price today?

Cerus Corp. (CERS) is currently trading at $ 2.37, up 2.38% ($0.06) from the previous close of $ 2.31. Intraday prices update in real time during regular trading hours.

2.Is CERS stock going up or down today?

As of 2026-10-21 15:58:56, CERS is trading at $ 2.37, up 2.38% ($0.06) from its previous close of $ 2.31. The stock has traded between $ 0.55 and $ 14.76 during today’s regular session. Past price movements do not guarantee future results.

3.What is CERS pre-market price?

As of 2026-10-21 15:58:56, CERS is trading at $ 2.32 in pre-market trading, up 0.43% ($0.01) from the previous close of $ 2.31. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CERS after-hours price?

As of 2026-10-21 15:58:56, CERS is trading at $ 2.31 in after-hours trading, unchanged from the regular-session close of $ 2.31. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CERS stock trading now?

CERS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CERS sit relative to its 52-week high and low?

Over the past 52 weeks, CERS has traded between a low of $ 1.38 and a high of $ 3.47. At $ 2.37, the stock is positioned 47.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cerus Corp. in?

Cerus Corp. (CERS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cerus Corp.'s market capitalization and where is it listed?

Cerus Corp. is listed on the NASDAQ exchange with a market capitalization of $ 447.39M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CERS valued in terms of P/E ratio and EPS?

CERS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.03. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cerus Corp. pay a dividend?

Cerus Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.